[Northern Light]

I did note the above seemed a plausble outcome, ....back when: (err, July 2024)

Far be it from me to defend what seems like a procedural mess, and Councillor Parking Lot.............

But....if one listens to what the Councillor said, he is clearly asserting that the Province has told him they will not let this go ahead, they will either remove it from the OLT or override the OLT.

I have not had that discussion with anyone in the Ministry and can't speak to its veracity, but Councillor Carroll who was the only one to oppose the Refusal, seems to suggest that those conversations
have indeed taken place; although she wanted to see this addressed by way of Referral rather than refusal.

You may have more insight on this.......

But if the province is going to either kibosh this outright, or reduce the approval to 10s, which apparently Sanofi has said they can live with............

This bit is interesting :

 

[Kenojuak]

Also reported in the Star with a similar note: https://www.thestar.com/real-estate...cle_17b28fb1-e3ab-4c06-9846-eccb3a0ee495.html

And actually the posting language on the ERO has some interesting detail and commentary: https://ero.ontario.ca/notice/025-1108

Decision details​

A Zoning Order, made pursuant to clause 47(1)(a) of the Planning Act, regulates the use of the land and the erection, location and use of any building or structure on the land. The Zoning Order was requested by the Minister of Economic Development, Job Creation and Trade in order to safeguard the continued operational viability of Sanofi Pasteur Limited’s (Sanofi) biomedical manufacturing facilities and headquarters.
Zoning Order 005-2026 applies to the lands located at 1875 Steeles Avenue West in the City of Toronto. The subject lands are approximately 1.28 hectares in size and are located at the south side of Steeles Avenue West, near the southeast corner of its intersection with Dufferin Street. The subject lands are currently occupied by a 4-storey residential apartment building.
Zoning Order 005-2026 restricts the heights of all buildings and structures on the subject lands to a maximum of 33 metres.
This Zoning Order made pursuant to clause 47(1)(a) of the Planning Act was posted for consultation as a regulation. Bill 60 received royal assent on November 27, 2025, and therefore this Order is not a regulation and will not be filed with the Registrar of Regulations. The Order came into effect upon signing by the Minister of Municipal Affairs and Housing.
Section 47 of the Planning Act provides a process for requests to amend a zoning order to be submitted to, and considered by, the Minister. Any requests to amend this Zoning Order would be considered in accordance with the Act, including balancing provincial interests such as increasing housing supply, protecting jobs and supporting economic development.

Effects of consultation​

All comments received were taken into consideration prior to a decision being made.
The proposal received comments from the public, several industry associations, local housing advocate organizations, local landowners and the City of Toronto.
There were comments received in support of the MZO from Sanofi Pasteur, industry associations (Life Sciences Ontario, Canadian Manufacturers and Exporters, Innovative Medicines Canada, Toronto Board of Trade and Toronto Industry Network), the City of Toronto and members of the public.
Sanofi Pasteur raised noise and security concerns that would lead to land use compatibility issues that would negatively impact the ongoing and future operation of the biomanufacturing facility and supported the MZO to protect against these impacts. The industry associations raised the need to protect for strategically important employment lands to sustain existing manufacturers and to provide support for future investment. The City of Toronto provided a Council resolution that endorsed the MZO to protect the long-term operational viability of Sanofi. Members of the public noted Sanofi pre-existed the proposed developments that surround it and that they operate a key role in making life science products for the public (e.g. vaccine production).
There were also a number of comments received in opposition to the MZO from the affected landowner at 1875 Steeles Avenue West, a neighbouring development proposal at 1881 Steeles Avenue West, the University of Toronto, two local housing advocate organizations (Federation of Rental Housing Providers of Ontario, Housing NowTO, More Neighbours Toronto) and a few members of the public.
The landowner of 1875 Steeles Avenue West noted the completion of studies accepted by city planning staff to show that noise or security compatibility issues were able to be appropriately mitigated with no impacts to Sanofi’s operations and opposed the MZO. The neighbouring landowner noted they had a similar development proposal and echoed the concerns of the owner of the subject lands that any land use compatibility impacts on the Sanofi facility can be appropriately mitigated.
The University of Toronto noted that the Sanofi site had originally been part of the neighbouring UofT campus, and the university has successfully coexisted with Sanofi for over 50 years and any height restrictions applied to the university lands would have significant impacts. Housing advocacy organizations noted their support for city staff’s position that more housing can be provided while adequately mitigating impacts on Sanofi. Members of the public expressed concern that the creation of much needed new housing would be held back by operational concerns of a private company.